| Trial ID: | L0259 |
| Source ID: | NCT00498342
|
| Associated Drug: |
N-Acetylcysteine
|
| Title: |
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: N-acetylcysteine
|
| Outcome Measures: |
Primary: Serum creatinine change at 4 hours and 48 hours following 4 doses of N-acetylcysteine (total 4800 mg) compared to baseline serum creatinine, 48 hours | Secondary: Serum Cystatin C change at 4 hours and 48 hours post 4 doses of N-acetylcysteine compared to baseline serum Cystatin C, 48 hours
|
| Sponsor/Collaborators: |
Sponsor: University of Vermont | Collaborators: FlowMedic
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2007-06
|
| Completion Date: |
2008-02
|
| Results First Posted: |
|
| Last Update Posted: |
2008-02-18
|
| Locations: |
University of Vermont /Fletcher Allen Health Care, Inc., Burlington, Vermont, 05401, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00498342
|
